p38α MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin-induced liver failure

91Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Activation of c-Jun amino-terminal kinase (JNK) facilitates tumour necrosis factor (TNF)-induced cell death. The p38 mitogen-activated protein kinase pathway is induced by TNF stimulation, but it has not been implicated in TNF-induced cell death. Here, we show that hepatocyte-specific ablation of p38α in mice results in excessive activation of JNK in the liver after in vivo challenge with bacterial lipopolysaccharide (LPS). Despite increased JNK activity, p38α-deficient hepatocytes were not sensitive to LPS/TNF toxicity showing that JNK activation was not sufficient to mediate TNF-induced liver damage. By contrast, LPS injection caused liver failure in mice lacking both p38α and IκB kinase 2 (IKK2) in hepatocytes. Therefore, when combined with partial nuclear factor-κB inhibition, p38α deficiency sensitizes the liver to cytokine-induced damage. Collectively, these results reveal a new function of p38α in collaborating with IKK2 to protect the liver from LPS/TNF-induced failure by controlling JNK activation.

Cite

CITATION STYLE

APA

Heinrichsdorff, J., Luedde, T., Perdiguero, E., Nebreda, A. R., & Pasparakis, M. (2008). p38α MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin-induced liver failure. EMBO Reports, 9(10), 1048–1054. https://doi.org/10.1038/embor.2008.149

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free